Suchergebnisse - "Davies, Jane C"

PubPharm (22)

1

Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER Trial

enthalten in: American journal of respiratory and critical care medicine | 2023

von McNally, P. | Lester, K. | Stone, G. | +25

CommentIn: Am J Respir Crit Care Med. 2023 Nov 1;208(9):911-913. - PMID 37756441

2

Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis : Results from the CLIMB-CF study

enthalten in: Pediatric pulmonology | 2023

von Edmondson, C. | Westrupp, N. | Short, C. | +23

3

Reply to migration is not the perfect answer : Optimized methodology to assess LCI agreement between corrected legacy multiple breath nitrogen washout data and that directly collected on updated software

enthalten in: Pediatric pulmonology | 2023

von De Queiroz Andrade, E. | Bailey, B. | Davies, J. | +5

4

Lytic Bacteriophage Is a Promising Adjunct to Common Antibiotics across Cystic Fibrosis Clinical Strains and Culture Models of Pseudomonas aeruginosa Infection

enthalten in: Antibiotics (Basel, Switzerland) | 2023

von Martin, I. | Morales, S. | Alton, E. | +1

5

Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation : A Phase 3b, Randomized, Placebo-controlled Study

enthalten in: American journal of respiratory and critical care medicine | 2022

von Mall, M. | Brugha, R. | Gartner, S. | +21

CommentIn: Am J Respir Crit Care Med. 2022 Dec 1;206(11):1308-1310. - PMID 35947636

6

Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa

enthalten in: Microbiology spectrum | 2022

von Murphy, R. | Coates, M. | Thrane, S. | +6

7

Going the Extra Mile : Why Clinical Research in Cystic Fibrosis Must Include Children

enthalten in: Children (Basel, Switzerland) | 2022

von Dobra, R. | Bentley, S. | Edmondson, C. | +6

8

Diversity and prevalence of type VI secretion system effectors in clinical Pseudomonas aeruginosa isolates

enthalten in: Frontiers in microbiology | 2022

von Robinson, L. | Collins, A. | Murphy, R. | +2

9

Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis : a systematic review

enthalten in: Therapeutic advances in respiratory disease | 2022

von Stanford, G. | Jones, M. | Charman, S. | +4

10

Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis

enthalten in: Thorax | 2021

von Bayfield, K. | Douglas, T. | Rosenow, T. | +10